Hjem › Overvægt › Rhode Island
Overvægt kliniske forsøg i Rhode Island
13 studier for Overvægt søger deltagere på steder i Rhode Island.
Byer i Rhode Island
Officiel studietekst (engelsk)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Providence, East Greenwich
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, East Greenwich
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- Women and Infants Hospital of Rhode Island, Providence
Rekrutterer
Alder 18 til 45 · Kvinder · Opdateret 24. jun. 2026 · NCT05124808Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
- Rhode Island Hospital, Providence
RekruttererFrivillige med god helbredstilstand velkomne
Alder 7 til 12 · Alle køn · Opdateret 7. maj 2026 · NCT06861868Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
Rekrutterer
Alder 18 til 70 · Alle køn · Opdateret 4. feb. 2026 · NCT07228130Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
- Weight Control and Diabetes Research Center, Providence
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 23. jan. 2026 · NCT07363616Weight Management Intervention in College: A Pilot
- The Miriam Hospital, Providence
Rekrutterer
Alder 18 til 29 · Alle køn · Opdateret 1. okt. 2025 · NCT06994923Control Systems Engineering for Weight Loss Maintenance
- Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 2. apr. 2024 · NCT06244888Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.